Insight & Intelligence

More »

February 1, Vol. 37, No. 3

  • Feature Articles

    • Next-Generation Sequencing Challenges
    • Shawn C. Baker
    • Over the past 10 years, next-generation sequencing (NGS) has grown by leaps and bounds Outputs have gone up, and costs have come down—both by orders of magnitude The NIH graph showing this progress is so overused that its main utility now ... more »
    • High Content—Less Mess, More Mesh
    • Richard A. Stein
    • One of the most significant advances that has occurred in life sciences over the last few decades is the development of novel technologies and platforms that have made it possible to generate vast datasets while decreasing costs and reducing timeframes ... more »
    • Biobanking for “All of Us”
    • Philippe Desjardins
    • The Precision Medicine Initiative (PMI) was created by the NIH to answer broad questions on a scale that might be missed by more specialized cohort collections The production of highly diverse libraries, on a population-wide scale of tens to hundreds ... more »
  • Columns

    • Insights
    • Johnson & Johnson (J&J) Innovation’s collaboration ecosystem stands at 300 strategic transactions and growing The newest 15 collaborations, announced recently, continue the J&J unit’s focus on partnering with early- and late-stage companies and institutions to develop new healthcare solutions in ... more »
    • Bringing Up Biologics, Dressing Up Dosages
    • Gail Dutton
    • As the development and commercialization of biologics and biosimilars continues apace, bipharma companies stay alert for new options in cell nutrition—anything to help them produce these biologically sourced therapeutics faster and more efficiently Biopharma companies are also keen to overcome ... more »